Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

June 29, 2021

FDA clears IND for clinical evaluation of CLBS-201 for diabetic kidney disease

June 23, 2021

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

June 14, 2021

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

June 11, 2021

Nippon Shinyaku patents muscarinic acetylcholine M3 receptor positive allosteric modulators

June 9, 2021

BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial

June 4, 2021

Pivotal study of venglustat in ADPKD stopped for futility

June 1, 2021

Targeting senescent cells restores kidney function

May 26, 2021

Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD

May 25, 2021

New phase Ib/IIa study evaluates VB-119 in membranous nephropathy

May 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...